Along with the evidence of A2AR and A2BR expression in tumor cells and different immune cell populations, further investigations are thus needed to explore whether inactivation of A2BR and/or A2AR in both tumor and immune cellular compartments elicits optimal antitumor T cell immunity upon 4-1BB costimulation by modulation of T cell metabolic fitness. Here, ADORA2A is linked to neoplasm.